Agilent Technologies to acquire Resolution Bioscience in $695m worth deal
Agilent Technologies, a US analytical instrumentation development and manufacturing company, has agreed to acquire Resolution Bioscience in a deal worth up to $695 million. Resolution Bioscience is a next generation sequencing (NGS) technology company based in Kirkland, Washington. The company is engaged in developing NGS-based precision oncology solutions. Agilent Technologies said that the deal complements […]